Study to evaluate efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol and 3 mg drospirenone in a 24-day regimen
Please see attached Study Results Summary below.
No Inclusion Criteria Available
No Exclusion Criteria Available
Multi-center, open, uncontrolled study to investigate the efficacy and safety of the oral contraceptive SH T 186 D containing 0.02 mg ethinylestradiol-beta-cyclodextrin clathrate and 3 mg drospirenone in a 24-day regimen for 13 cycles in 1010 healthy female volunteers